80. http:// doctor.ru/medinfo
81. Hund E., Jansen O., Koch M. et al. Proximal myotonic myopathy with MRI white matter abnormalities of the brain // Neurology. — 2001. — Vol. 48. — P. 33-37.
82. Ishikawa Y, Bach JR, Sarma RJ et al., Cardiovascular consideration in the management of neuromuscular disease. Seminars in neurology,1995.
83. Jiang H., Mankodi A., Swanson M.S. et al. Myotonic dystrophy type 1 associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins, and deregulated alternative splicing in neurons // Hum. Mol. Genet. — 2004. — Vol. 13. — P.3079-3088.
84. Kaplan J.C., Fontaine В. Neuromuscular disorders: gene location. Neuromusc Disord 1999.
85. Kay M., Liu D, Hoogerbrugge P.M. Proc. Natl. Acad. Sci. USA, 94, 1997.
86. Khurana T.S., Prendergast R.A., Alameddine H. et al. J Exp Med 1995.
87. Le-Thiet-Thanh; Nguyen-Thi-Man; Hori-S; Sewry-CA; Dubowitz-V; Morris-GE Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin. Am-J-Med-Genet. 58(2), 1995.
88. Lim L.E., Duclos P., Broux O. et al. Nat Genet 11;1995.
89. Liu J., Aoki M., Illa I. et al. Nat Genet 20;1998.
90. Maeda M; Nakao S; Miyazato H; et al. Cardiac involvement in Becker muscular dystrophy J-am-coll-cardiol. 22/7, 1996.
91. McKusik V., Amberger J. The morbid anatomy of the human genome chromosomal location causing disease J. Med. Genet. 2003.
92. McNally E., Passos-Bueno R., Bonnemann C.G. et al. Am J Hum Genet 1996.
93. Meola G. Clinical and genetic heterogeneity in myotonic dystrophies // Muscle Nerve — 2000. — Vol. 23. — P. 1789-1799.
94. Minetti C., Sotgia F., Bruno C. et al. Nat Genet 18; 1998.
95. Mirabella M., Silvester G., Rosa G. et al. GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology 2000.
96. Moreira E., Vainzof M., Marie S. et al. Am J Hum Genet 61; 1997.
97. Moxley R.T. IIIrd, Udd B., Ricker K. Proximal myotonic myopathy (PROMM) and other proximal myotonic syndromes // Neuromuscul. Disord. — 2000. — Vol. 8. — P. 519-520.
98. Muntoni F., Mateddu A., Marchei F. et al. J Neurol Sci l20; 1993.
99. Nevo Y., Muntoni F., Sewery C. et al. Neuromusc Disorders 1998.
100. Nigro V., de Sa Moreira E., Piluso G. et al. Nature Genet 14; 1996.
101. Novakovic I., Todorovic S., Apostolski S. et al. Neuromusc Disord 1998.
102. Novelli G., Genarelli M., Menegazzo E. et al. (CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy // Biochem. Med. Metab. Biol. — 2003. — Vol. 50. — P. 85-92.
103. Ono S., Takahashi K., Jinnai K. et al. Loss of serotonin-containing neurons in the raphe of patientswith myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia // Neurology. — 2003. — Vol. 50. — P. 535-538.
104. Palmucci L., Doriguzzi C., Mongini T. et al. Neurology 2004.
105. Partridge T., Lu Q.L., Morris G., Hoffman E Nature Medicine, 4, 1998
106. Penninger J.M., Neu N., Bachmaier К. The Immunologist 1996.
107. Piantadosi C., Nigro V., Servider S. et al. Neuromusc Disorders 1998.
108. Piccolo F., Roberds S.L., Jeanpierre M. et al. Nat Genet 10; 1995.
109. Porter J.D. Neuromusc Disord 1998.
110. Quinlivan-RM; Dubowitz-V Cardiac transplantation in Becker muscular dystrophy. Neuromuscul-Disord. 1992.
111. Rando T.A., Dziesietnik M.H., Dhawan J. et al. Neurology 1997.
112. Rees W; Schuler S; Hummel M; Hetzer R - Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy J-heart- lung-transplant. 12/5, 1993.
113. Richard I., Brenguier L., Dincer P. et al. Am J Hum Genet 60; 1997.
114. Saito K.et al - Molecular genetic analysis of Duchenne/Becker muscular dystrophy families. In: Сlin-neurol. - 2002.
115. Sharma K.R., Mynhies M.A., Robert Y., Miller R.Y. Neurology 1993.